臨床試驗

Magseed Pro(R)/ Sentimag(R) Gen3

NCT：NCT05142787 · RECRUITING

NCT IDNCT05142787

狀態RECRUITING

開始日期2023-03-02

完成時間2028-06-30

SponsorEndomagnetics Ltd. (INDUSTRY)

First posted2021-12-03

Last updated2026-09-16

簡要摘要

The purpose of this study is to provide prospective evidence that the Magseed Pro® marker /Sentimag® Gen3 system is safe and effective for marking A. suspicious/biopsy-proven positive axillary lymph nodes; and B. soft tissue lesions including cancer and pre-cancerous change in the breast

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。